Cannabis use disorder among atrial fibrillation admissions, 2008–2018

Fouad Chouairi, P. Elliott Miller, Avirup Guha, John Ross Clarke, Samuel W. Reinhardt, Tariq Ahmad, James V. Freeman, Nihar R. Desai, Daniel J. Friedman

Research output: Contribution to journalArticlepeer-review


Background: Despite changes inthe legality of cannabis use and the increasing prevalence of cannabis use disorder (CUD), there is little data investigating the association between CUD and inpatient atrial fibrillation (AF) hospitalizations. Methods: Using the National Inpatient Sample, we identified Atrial Fibrillation (AF) hospitalizations with and without a codiagnosis of CUD using International Classification of Diseases diagnosis codes and compared demographics, socioeconomics, comorbidities, outcomes, and trends between cohorts. Results: Between 2008 and 2018, we identified 5,155,789 admissions for AF of which 31,768 (0.6%) had a codiagnosis of CUD. The proportion of admissions with a history of CUD increased from 0.3% in 2008 to 1.0% in 2018 (p 
Original languageEnglish (US)
Pages (from-to)1934-1938
Number of pages5
JournalPACE - Pacing and Clinical Electrophysiology
Issue number11
StatePublished - Nov 1 2021


  • NIS
  • National Inpatient Sample
  • atrial fibrillation
  • cannabis use disorder
  • disparities
  • outcomes


Dive into the research topics of 'Cannabis use disorder among atrial fibrillation admissions, 2008–2018'. Together they form a unique fingerprint.

Cite this